Orchestra BioMed Holdings, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-272.4K | $-272.4K | — | — |
| FY2022 | $-29.3M | $-29.9M | $591.0K | $3.4M |
| FY2023 | $-46.1M | $-46.2M | $78.0K | $7.6M |
| FY2024 | $-50.6M | $-50.8M | $289.0K | $10.6M |
| FY2025 | $-49.0M | $-49.5M | $489.0K | $12.0M |